‘Golden Era’ of Medication Meets Geopolitical Uncertainty
In this episode of Wall Street Week, we talk to a longtime diplomat and the CEO of Johnson & Johnson
Joaquin Duato, CEO of Johnson & Johnson
Photographer: Gabby Jones/BloombergWelcome to the Wall Street Week newsletter, bringing you stories of capitalism about things you need to know, but even more things you need to think about. I'm David Westin, and this week diplomat Richard Haass took us through the conflict between Israel and Iran, while Johnson & Johnson CEO Joaquin Duato took us into the the world of biotech innovation. If you're not yet a subscriber, sign up here for this newsletter.
This week the Middle East was thrust into turmoil when Israel launched an attack on Iran's nuclear projects and some of its top military leadership. Richard Haass served in a series of foreign policy positions in the White House and the State Department and went on to lead the Council on Foreign Relations for over 20 years. He told us that, at this point, we have more questions than answers, including about "what more Israel plans to do," with Iran having a "massive set of options."